Insider · CIK 0001779707
Christopher Van Tuyl
officer
Files at IMVT (Immunovant, Inc.). First filing Dec 19, 2025, latest Oct 9, 2026.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 3
$0 bought, $437k sold
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMVT: Immunovant, Inc.
IMVTOct 9, 2026 · close 30.47
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 36Weak | Immunovant, Inc. | $43k 1,327 shares | -1% | +99% from low-29% from high | |
| 40Moderate | Immunovant, Inc. | $103k 2,846 shares | -2% | +132% from low-23% from high | |
| 29Weak | IMVTsell Immunovant, Inc. | $291k 10,813 shares | -7% | +97% from low-3% from high |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -1,327 | $32.06 | $43k | 175,218 | 3 d ago |
| Sep 23, 2026 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,846 | $36.36 | $103k | 176,545 | 17 d ago |
| Dec 18, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -8,529 | $26.78 | $228k | 152,214 | Dec 19, 2025 |
| Dec 18, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,284 | $27.38 | $63k | 149,930 | Dec 19, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Common Stock | +50,787 | $0.00 | $0 | 160,743 | Apr 3, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Stock Option (right to buy)derivative | +71,531 | $0.00 | $0 | 71,531 | Apr 3, 2025 |
| Dec 16, 2024 | IMVT Immunovant, Inc. | AGrant or award Common Stock | +109,956 | $0.00 | $0 | 109,956 | Dec 18, 2024 |
| Dec 16, 2024 | IMVT Immunovant, Inc. | AGrant or award Stock Option (right to buy)derivative | +137,446 | $0.00 | $0 | 137,446 | Dec 18, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.